生物学的安全キャビネット市場：タイプ別、エンドユーザー別-2025～2030年の世界予測

生物学的安全キャビネット市場は、2023年に4億5,646万米ドルと評価され、2024年には4億9,474万米ドルに達すると予測され、CAGR 8.47%で成長し、2030年には8億693万米ドルになると予測されています。

調査（BSC）とは、利用者と環境を病原性微生物から守るために設計された、密閉され換気された研究所の作業スペースのことで、生物医療、製薬、バイオテクノロジーの研究に応用されています。BSCの必要性は、実験室、産業環境、医療施設におけるバイオセーフティの確保と汚染防止に重要な役割を果たすことで強調されています。用途と最終用途の範囲は研究機関や臨床検査室から病院や製薬会社まで広大であり、COVID-19のような世界の健康脅威の中で厳格な安全基準の必要性によって採用が増加しています。BSC市場に影響を与える重要な成長要因には、感染症の増加、バイオセキュリティへの懸念の高まり、実験従事者の安全性に関する厳格な規制枠組みなどがあります。改良されたエアフローシステムや先進的濾過技術などの技術的進歩は、特に新興市場における研究開発や医療インフラへの投資の増加とともに、潜在的な成長機会を提供しています。しかし、市場の成長は、初期コストの高さ、複雑なメンテナンス要件、規制機関からの承認プロセスの長さといった課題に直面しており、小規模ラボがBSCを採用することを躊躇させる可能性があります。新たなビジネス機会を生かすため、企業は、エネルギー効率の高いモデルの開発、デジタル監視システムの統合、設計・製造における環境に優しい材料の探求など、イノベーションのセグメントに注力することができます。また、研究機関との提携や協力を促進することで、革新的なソリューションを推進することもできます。市場競争は緩やかで、主要参入企業は市場での存在感を維持し、進化する安全基準に準拠するため、常に技術革新に取り組んでいます。事業成長を目指す企業は、強固な研究開発戦略に投資し、新興市場を開拓し、特定の研究所の要件を満たすカスタマイズを提供すべきです。このような研究中心のイノベーション・アプローチは、既存の市場課題を克服し、バイオセーフティ・キャビネットの需要拡大に効果的に対応するのに役立つと考えられます。

市場力学：急速に進化する生物学的安全キャビネット市場の主要市場洞察を公開

生物学的安全キャビネット市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 医療業界における生物学的安全キャビネットの使用を促進する有利な規制
  • パンデミックや伝染病のリスク増大
  • 生物製剤数の急増
• 市場抑制要因
  • 代替格納キャビネット
• 市場機会
  • バイオ医薬品と製薬企業における研究開発活動の増加
  • 生物製剤数の急速な増加成長国における医療インフラへの投資の増加
• 市場課題
  • 低コストの高品質生物学的安全キャビネットの開発

ポーターの5つの力：生物学的安全キャビネット市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：生物学的安全キャビネット市場における外部からの影響の把握

外部マクロ環境要因は、生物学的安全キャビネット市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：生物学的安全キャビネット市場における競合情勢の把握

生物学的安全キャビネット市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス生物学的安全キャビネット市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生物学的安全キャビネット市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：生物学的安全キャビネット市場における成功への道筋を描く

生物学的安全キャビネット市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医療業界における生物学的安全キャビネットの使用を促進する有利な規制
    • パンデミックや伝染病のリスク増加
    • 生物製剤の急速な増加
  • 抑制要因
    • 代替収容キャビネット
  • 機会
    • バイオ医薬品と製薬企業における研究開発活動の増加
    • 生物製剤の急速な増加により、成長経済における医療インフラへの投資が増加
  • 課題
    • 低コストで高品質な生物学的安全キャビネットの開発
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 生物学的安全キャビネット市場：タイプ別

• イントロダクション
• クラスI
• クラスII
  • クラスIIタイプ A
  • クラスIIタイプB
• クラスIII

第7章 生物学的安全キャビネット市場：エンドユーザー別

• イントロダクション
• 学術・研究機関
• 診断と検査研究所
• 製薬・バイオ医薬品企業

第8章 南北アメリカの生物学的安全キャビネット市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の生物学的安全キャビネット市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの生物学的安全キャビネット市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Air Science USA LLC by PyroGenesis Canada Inc.
• Alpha Linear
• Berner International GmbH
• Biobase Biodusty（Shandong）, Co., Ltd.
• Esco Micro Pte. Ltd.
• EuroClone S.p.A.
• Flow Sciences, Inc.
• Germfree Laboratories, Inc.
• Haier Biomedical
• Kewaunee Scientific Corporation
• Labconco Corporation
• Stericox India Private Limited
• The Baker Company
• Thermo Fisher Scientific Inc.
• TopAir Systems Inc.

LIST OF FIGURES

• FIGURE 1. BIOLOGICAL SAFETY CABINET MARKET RESEARCH PROCESS
• FIGURE 2. BIOLOGICAL SAFETY CABINET MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOLOGICAL SAFETY CABINET MARKET DYNAMICS
• TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS & TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 30. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 50. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 102. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 114. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 117. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023

The Biological Safety Cabinet Market was valued at USD 456.46 million in 2023, expected to reach USD 494.74 million in 2024, and is projected to grow at a CAGR of 8.47%, to USD 806.93 million by 2030.

A Biological Safety Cabinet (BSC) is an enclosed, ventilated lab workspace designed to protect both the user and the environment from pathogenic microorganisms, with applications spanning biomedical, pharmaceutical, and biotechnological research. The necessity of BSCs is underscored by their critical role in ensuring biosafety and preventing contamination in laboratories, industrial settings, and healthcare facilities. The application and end-use scope are vast, extending from research institutions and clinical laboratories to hospitals and pharmaceutical companies, with increasing adoption driven by the need for stringent safety standards amid global health threats like COVID-19. Significant growth factors influencing the BSC market include the rise of infectious diseases, escalating biosecurity concerns, and stringent regulatory frameworks regarding laboratory personnel safety. Technological advancements, such as improved airflow systems and advanced filtration technologies, offer potential growth opportunities, along with increased investment in R&D and healthcare infrastructure, particularly in emerging markets. However, market growth faces challenges such as high initial costs, complex maintenance requirements, and a lengthy approval process from regulatory bodies, which may deter small-scale labs from adopting BSCs. To capitalize on emerging opportunities, companies can focus on areas of innovation, such as developing energy-efficient models, integrating digital monitoring systems, and exploring eco-friendly materials in design and manufacturing. Encouraging partnerships and collaborations with research institutions can also drive forward innovative solutions. The market presents a moderately competitive landscape with key players consistently innovating to maintain market presence and comply with evolving safety standards. Enterprises aiming for business growth should invest in robust R&D strategies, tap into emerging markets, and offer customization to meet specific lab requirements. This research-centered innovation approach could help in overcoming the existing market challenges and cater to the growing biosafety cabinet demand effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Safety Cabinet Market

The Biological Safety Cabinet Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Favorable regulations driving the use of biological safety cabinets in the healthcare industry
  • Increased risk of pandemics and communicable diseases
  • Rapid growth in the number of biologics
• Market Restraints
  • Alternative containment cabinet
• Market Opportunities
  • Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
  • Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
• Market Challenges
  • Development of low cost high quality biological safety cabinets

Porter's Five Forces: A Strategic Tool for Navigating the Biological Safety Cabinet Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Safety Cabinet Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Safety Cabinet Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Safety Cabinet Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Safety Cabinet Market

A detailed market share analysis in the Biological Safety Cabinet Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Safety Cabinet Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Safety Cabinet Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Safety Cabinet Market

A strategic analysis of the Biological Safety Cabinet Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Safety Cabinet Market, highlighting leading vendors and their innovative profiles. These include Air Science USA LLC by PyroGenesis Canada Inc., Alpha Linear, Berner International GmbH, Biobase Biodusty (Shandong), Co., Ltd., Esco Micro Pte. Ltd., EuroClone S.p.A., Flow Sciences, Inc., Germfree Laboratories, Inc., Haier Biomedical, Kewaunee Scientific Corporation, Labconco Corporation, Stericox India Private Limited, The Baker Company, Thermo Fisher Scientific Inc., and TopAir Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Safety Cabinet Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Class I, Class II, and Class III. The Class II is further studied across Class II Type A and Class II Type B.
• Based on End User, market is studied across Academic & Research Organizations, Diagnostics & Testing Laboratories, and Pharmaceutical & Biopharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Favorable regulations driving the use of biological safety cabinets in the healthcare industry
    • 5.1.1.2. Increased risk of pandemics and communicable diseases
    • 5.1.1.3. Rapid growth in the number of biologics
  • 5.1.2. Restraints
    • 5.1.2.1. Alternative containment cabinet
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
    • 5.1.3.2. Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
  • 5.1.4. Challenges
    • 5.1.4.1. Development of low cost high quality biological safety cabinets
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biological Safety Cabinet Market, by Type

• 6.1. Introduction
• 6.2. Class I
• 6.3. Class II
  • 6.3.1. Class II Type A
  • 6.3.2. Class II Type B
• 6.4. Class III

7. Biological Safety Cabinet Market, by End User

• 7.1. Introduction
• 7.2. Academic & Research Organizations
• 7.3. Diagnostics & Testing Laboratories
• 7.4. Pharmaceutical & Biopharmaceutical Companies

8. Americas Biological Safety Cabinet Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biological Safety Cabinet Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biological Safety Cabinet Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Air Science USA LLC by PyroGenesis Canada Inc.
• 2. Alpha Linear
• 3. Berner International GmbH
• 4. Biobase Biodusty (Shandong), Co., Ltd.
• 5. Esco Micro Pte. Ltd.
• 6. EuroClone S.p.A.
• 7. Flow Sciences, Inc.
• 8. Germfree Laboratories, Inc.
• 9. Haier Biomedical
• 10. Kewaunee Scientific Corporation
• 11. Labconco Corporation
• 12. Stericox India Private Limited
• 13. The Baker Company
• 14. Thermo Fisher Scientific Inc.
• 15. TopAir Systems Inc.